| Product NDC: | 63323-145 |
| Proprietary Name: | Floxuridine |
| Non Proprietary Name: | FLOXURIDINE |
| Active Ingredient(s): | 500 mg/5mL & nbsp; FLOXURIDINE |
| Administration Route(s): | INTRA-ARTERIAL |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63323-145 |
| Labeler Name: | APP Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075837 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20010315 |
| Package NDC: | 63323-145-07 |
| Package Description: | 1 VIAL in 1 CARTON (63323-145-07) > 5 mL in 1 VIAL |
| NDC Code | 63323-145-07 |
| Proprietary Name | Floxuridine |
| Package Description | 1 VIAL in 1 CARTON (63323-145-07) > 5 mL in 1 VIAL |
| Product NDC | 63323-145 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | FLOXURIDINE |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRA-ARTERIAL |
| Start Marketing Date | 20010315 |
| Marketing Category Name | ANDA |
| Labeler Name | APP Pharmaceuticals, LLC |
| Substance Name | FLOXURIDINE |
| Strength Number | 500 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Antimetabolite [EPC],Deoxyuridine [Chemical/Ingredient] |